Northern Trust’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-39,501
| Closed | -$441K | – | 4706 |
|
2022
Q4 | $441K | Buy |
39,501
+4,444
| +13% | +$49.6K | ﹤0.01% | 3551 |
|
2022
Q3 | $197K | Buy |
35,057
+3,664
| +12% | +$20.6K | ﹤0.01% | 3880 |
|
2022
Q2 | $136K | Sell |
31,393
-73,280
| -70% | -$317K | ﹤0.01% | 4059 |
|
2022
Q1 | $1.22M | Sell |
104,673
-5,047
| -5% | -$58.7K | ﹤0.01% | 3338 |
|
2021
Q4 | $2M | Sell |
109,720
-1,419
| -1% | -$25.9K | ﹤0.01% | 3225 |
|
2021
Q3 | $1.32M | Sell |
111,139
-7,366
| -6% | -$87.3K | ﹤0.01% | 3454 |
|
2021
Q2 | $2.04M | Buy |
118,505
+27,113
| +30% | +$466K | ﹤0.01% | 3348 |
|
2021
Q1 | $1.67M | Sell |
91,392
-10,683
| -10% | -$195K | ﹤0.01% | 3343 |
|
2020
Q4 | $1.92M | Buy |
102,075
+2,583
| +3% | +$48.6K | ﹤0.01% | 3217 |
|
2020
Q3 | $2.1M | Buy |
99,492
+6,531
| +7% | +$138K | ﹤0.01% | 3040 |
|
2020
Q2 | $2.68M | Buy |
92,961
+23,872
| +35% | +$689K | ﹤0.01% | 2871 |
|
2020
Q1 | $2.42M | Buy |
69,089
+3,535
| +5% | +$124K | ﹤0.01% | 2748 |
|
2019
Q4 | $1.6M | Buy |
+65,554
| New | +$1.6M | ﹤0.01% | 3234 |
|